A Rare Case of Aluminum Phosphide Induced Thrombotic Thrombocytopenic Purpura
Aluminum phosphide (AlP) has remained a chemical cause of completed suicides in some developing countries. ALP toxicity can cause multi-system damage. As far as we know, this is the first case of ALP-induced Thrombotic Thrombocytopenic Purpura (TTP) and its successful management. A 34-year-old man, who had attempted suicide with ALP was admitted to our hospital. On the 3rd day of admission, the patient developed hematuria, hemolysis, and thrombocytopenia. Based upon available evidence, TTP was diagnosed. Following a complete patient evaluation, ALP was recognized as the probable cause of TTP. Following the treatment using prednisolone and therapeutic plasma exchange, the patient substantially improved. Finally, he was discharged on the 22nd day. Toxin-induced intravascular hemolysis should be considered for patients presenting with ALP toxicity. As reported in this patient, TTP is another manageable consequence of ALP poisoning.
2. Farahani MV, Marashi SM. Sophism in the Management of Acute Aluminum Phosphide Poisoning may Cause Patient Harm. Indian J Crit Care Med 2017;21(3):182-182.
3. Etemadi-Aleagha A, Akhgari M, Iravani FS. Aluminum Phosphide Poisoning-Related Deaths in Tehran, Iran, 2006 to 2013. Medicine 2015;94(38):e1637.
4. Bhalla A, Mahi S, Sharma N, et al. Polyserositis: An unusual complication of aluminum phosphide poisoning. Asia Pacific Journal of Medical Toxicology 2012;1(1):14-17.
5. Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminium phosphide poisoning. Arh Hig Rada Toksikol 2012;63(1):61-73.
6. Malakar S, Negi BD, Dutt K, et al. Intravascular Hemolysis in Aluminum Phosphide Poisoning. Indian J Crit Care Med 2019;23(2):106-107.
7. Sanaei-Zadeh H. Aluminum phosphide poisoning and development of hemolysis and methemoglobinemia. Indian J Crit Care Med 2012;16(4):248-249.
8. Soltaninejad K, Nelson LS, Khodakarim N, et al. Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment. Indian J Crit Care Med 2011;15(2):117-119.
9. Marik PE. Is intravenous vitamin C contraindicated in patients with G6PD deficiency? Crit Care 2019;23(1):109.
10. Burka ER, Weaver Z 3rd, Marks PA. Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1966;64(4):817-25.
11. Bendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 2017;4(4):e157-e164.
|Issue||Vol 9, No 3 (Summer 2021)|
|Aluminum Phosphide; Thrombotic Thrombocytopenic Purpura; Plasmapheresis; Corticosteroids|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|